期刊文献+

组合术式治疗大龄儿童先天性髋关节脱位的临床研究 被引量:2

Combined Operation Treatment of Congenital Dislocation of Hips in Older Children
下载PDF
导出
摘要 【目的】设计并使用组合术式治疗大龄儿童先天性髋关节脱位(CDH),以降低股骨头坏死率及髋关节病残率,提高治愈率。【方法】自1990年至2006年作者使用组合术式(切开复位+骨盆内移截骨+髋臼成形+股骨转子下旋转缩短截骨术)治疗大龄儿童(7-15岁)CDH 67例91髋,随访时间1年至15年3个月,平均随访时间7年4个月。【结果】本组病例依照Trevor评分优良率达到81.3%,股骨头无菌性坏死15髋,占16.5%,髋关节僵硬12髋,占13.2%,比照Salter标准,股骨头坏死率和病残率明显降低。【结论】组合术式治疗大龄儿童CDH疗效良好,它符合髋关节生物力学特点,符合患儿病理解剖特点;利用组合术式优势降低了股骨头坏死率及髋关节病残率,提高了治愈率。 [Objective]To investigate how to increase the cure rate , reduce necrosis rate of femoral head and stiffness rate of hip joint in the operation for congenital hip dislocation. [Methods]Form 1990 to 2006, 91 hips in 67 cases of congenital hip dislocation aged 7-year to 15-year old, were treated by combined operation, and were followed-up from 1 year to 15 years and 3 months(average,7 years and 4 months). [Results]According to the modified rating system of Trevor, 81.3 % of the whole series had a good or excellent result. Fifteen (16.5%) ischemic necroses of femoral head occurred . The rate of ischemic necrosis of the femoral head and joint stiffness of hip in older age children after operation were reduced obviorsly according to the standard by Salter. [Conclusion]The combined operative treatment improves the biomechanical relation of the hip. It's preferred in treating the congenital hip dislocation of older age children. It reduces the rate of ischemic necrosis of femoral head and joint stiffness of hip and increases the rate of cure.
出处 《医学临床研究》 CAS 2007年第2期183-186,共4页 Journal of Clinical Research
基金 深圳市科技立项课题(编号:深卫科200006011)
关键词 髋脱位 先天性/外科学 hip dislocation,congenital/SU
  • 相关文献

参考文献10

二级参考文献38

  • 1周永德,吉士俊.先天性髋脱位疗效评定标准[J].中华小儿外科杂志,1994,15(3):189-189. 被引量:175
  • 2[15]Raff ML,Craigen WJ,Smith LT,et al.Partial COL1A2 gene duplication produces features of osteogenesis imperfecta and Ehlers-Danlos syndrome type Ⅶ[J].Hum Genet,2000,106:19~28.
  • 3[16]Kuivaniemi H,Tromp G,Prockop DJ.Mutations in fibrillar collagens,fibr1-associated collagen,and network-forming cause a spectrum of disease of bone,cartilage,and blood vessels[J].Hum Mutat,1997,9:300~315.
  • 4[17]Colige A,Sieron AL,Li SW,et al.Human Ehlers-danlos syndrome type Ⅶ C and bovine dermatosparaxis are caused by mutations in the procollagen ⅠN-proteinase gene[J].Am J Hum Genet,1999,65:308~317.
  • 5[18]Lee B,Godfrey M,Vitale E,et al.Linkage of Marfan syndrome and a phenotypically related disorder to two different fibrillin genes[J].Nature,1991,352:330~334.
  • 6[19]Dietz HC,Cutting GR,Pyeritz RE,et al.Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene[J].Nature,1991,352:337~339.
  • 7[20]Liu W,Qian C,Comeau K,et al.Mutant fibrillin-1 monomers lacking EGF-like domains disrupt microfibri assembly and cause severe marfan syndrome[J].Hum Molec Genet,1996,5:1581~1587.
  • 8[21]Robinson PN,Godfrey M.The molecular genetics of Marfan syndrome and related microfibrillopathies[J].J Med Genet,2000,37:9~25.
  • 9[22]Pepe G,Giusti B,Evangelisti L,et al.Fibrillin-1 gene frameshift mutations in Marfan patients:genotype-phenotype correlation[J].Clin Genet,2001,59:444~450.
  • 10[23]Toudjarska Ⅰ,Klipatrick MW,Lembesis P,et al.Novel approach to the molecular diagnosis of Marfan syndrome:application to sporadic cases and in prenatal diagnosis [J].Am J Med Genet,2001,99:294~302.

共引文献49

同被引文献15

引证文献2

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部